CROI 2013: Tenofovir Alafenamide Appears Easier on Kidneys
A new pro-drug formulation of the widely used nucleotide reverse transcriptase inhibitor analog...
Read More
Author: PWeekly
CROI 2013: HIV Testing in Commercially Insured Pregnant Women
The Particulars: Identification of HIV infection before or during pregnancy allows for...
Read More
CROI 2013: CD4 Counts in Youth With Behaviorally Acquired HIV
The Particulars: Research indicates that HIV incidence is increasing among youth. Although public...
Read More
CROI 2013: Health Insurance & Durable Viral Suppression
The Particulars: Policies to improve the health of patients with HIV may be guided by nationally...
Read More
CROI 2013: Smoking Among Patients with HIV
The Particulars: Previous research suggests that as many as 70% of patients with HIV smoke...
Read More
CROI 2013: The Impact of the CDC’s Opt-out HIV Testing Recommendation
The Particulars: Since 2006, the CDC has recommended routine opt-out HIV testing for early...
Read More
CROI 2013: All-Oral Regimens Work in HCV
ATLANTA – All-oral regimens under investigation for hepatitis C virus (HCV) were able to cure up...
Read More
CROI 2013: Drug Combo Scores Early Against HCV/HIV
ATLANTA – A protease inhibitor being investigated in patients co-infected with the hepatitis C...
Read More
CROI 2013: VOICE Trial Results
Results from a large-scale HIV prevention trial among African women known as VOICE (Vaginal and...
Read More
CROI 2103: Select CDC Studies of Interest
CDC scientists will be presenting more than 40 abstracts at CROI 2013. Several studies that may be...
Read More
CROI 2013: Very Early Antiretroviral Treatment Limits the Size of HIV Reservoir
Very early antiretroviral treatment may limit the size of the HIV reservoir in adults and...
Read More
CROI 2013: Pre-exposure HIV Prophylaxis Type Doesn’t Matter
ATLANTA — A large study to determine if pre-exposure prophylaxis could prevent HIV transmission...
Read More
CROI 2013: Extra Drug Hikes HCV Regimen’s Efficacy
ATLANTA – Adding an extra drug to a promising hepatitis C (HCV) regimen increased its efficacy –...
Read More
CROI 2013: HIV Drugs Ease Inflammation in ‘Controllers’
ATLANTA – Putting HIV controllers — who ordinarily don’t need therapy — on highly active...
Read More
CROI 2013: ‘Functional Cure’ Seen in HIV-Infected Child
ATLANTA — Researchers reported here that a child born with HIV infection and treated in infancy...
Read More
FDA Approves Osphena for Postmenopausal Women With Pain During Sex
The U.S. Food and Drug Administration today approved Osphena (ospemifene) to treat women...
Read More
FDA Approves Stivarga for Advanced Gastrointestinal Stromal Tumors
The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafenib) to...
Read More
Kadcyla Approved for Late-Stage Breast Cancer
The U.S. Food and Drug Administration today approved Kadcyla (ado-trastuzumab emtansine), a new...
Read More
First Retinal Implant for Rare Genetic Eye Disease
The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the...
Read More